Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03504007 · ClinicalTrials.gov registry record
Registry of Patients Prescribed Anticoagulation
A clinical trial of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT03504007: Recruiting study of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis, sponsored by Mayo Clinic.
NCT03504007 is a study of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10,000 participants, above the 117-participant average among 3 other Acute Pulmonary Embolism trials with a reported enrollment target (8447% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03504007, a study of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Gonda Vascular Center- Thrombophilia Clinic at Mayo Clinic in Rochester, Minnesota utilizes a standardized, guideline-directed, yet patient-oriented approach for treating patients diagnosed with venous thromboembolism (VTE).This study is the ongoing registry of clinical practice with standardized approach to patient assessment and therapy. As most of registries it does not have any definite number of recruited subjects or the date of study completion but provides anticipated number of recruited subjects and the time of anticipated enrolment which was provided only because of formal requirement related to structure of ClinicalTrials.gov website. This number will be updated and upgraded as we continue this registry. The rates of VTE recurrence, major bleeding, clinically relevant non-major bleeding (CRNMB) and survival in patients treated with anticoagulation for acute VTE are assessed during prospective observation. VTE cases include an acute deep vein thrombosis (DVT) of lower or upper extremities, splanchnic veins, gonadal, renal, cerebral veins thrombosis and pulmonary embolism (PE). Therapy includes the whole spectrum of FDA approved anticoagulants such as "classic" agents: warfarin and heparinoids and the newer direct oral anticoagulants (DOACs) such as rivaroxaban, dabigatran, apixaban, and edoxaban.
Primary Outcome
Recurrent VTE clearly new compared to previous VTE. Major bleeding by ISTH definition
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2013-03-01 |
| Est. Completion | 2033-03 |
What NCT03504007 shows while recruiting
NCT03504007 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 117-participant average among 3 other Acute Pulmonary Embolism trials with a reported enrollment target (8447% higher).
The record links to 2 conditions, with Acute Pulmonary Embolism appearing as the primary indexed condition, and to 0 interventions.
NCT03504007 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03504007 about?
NCT03504007 is a clinical study titled "Registry of Patients Prescribed Anticoagulation". The Gonda Vascular Center- Thrombophilia Clinic at Mayo Clinic in Rochester, Minnesota utilizes a standardized, guideline-directed, yet patient-oriented approach for treating patients diagnosed with venous thromboembolism (VTE).This study is the ongoing registry of clinical practice with standardize...
What is the current status of trial NCT03504007?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2013-03-01. Estimated completion is 2033-03.
What conditions does trial NCT03504007 study?
This clinical trial studies the following conditions: Acute Pulmonary Embolism, Acute Deep Vein Thrombosis.
Who is sponsoring clinical trial NCT03504007?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03504007 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI